tp3805
Small moleculeexperimentalImaging agent
Clinical trial activity
4 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2008 (NCT02810873)
Timeline
2010s
- Jan 1, 2013
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 64-copper
Oral
No
Parenteral
No
Topical
No
Also known as
- tp3805
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03039413 | Early Phase 1 (Phase 1) | Sep 28, 2016 | Thomas Jefferson University |
| NCT02989623 | N/A | Sep 1, 2015 | National Institutes of Health (NIH), Thomas Jefferson University |
| NCT02603965 | Phase 1 | Aug 1, 2013 | National Institutes of Health (NIH), Thomas Jefferson University |
| NCT02810873 | N/A | Sep 1, 2008 | National Institutes of Health (NIH), Thomas Jefferson University |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Thomas Jefferson University | Academic/Hospital | 4 | 4 | 2 | 2008 |
| National Institutes of Health (NIH) | Government | 3 | 0 | 2 | 2008 |
2 organizations
Page 1 / 1